Positive news and deals at the CACLP, with an already improved sales pipeline in place with GeneoDx, should see cash flow from prospective customers in 2 quarters, at the earliest, in my humble opinion.
So around Sept/ Oct period.
Ellume related income could be earlier, but not very likely, IMO.
This is still in time to generate enough volume to finance salaries and fixed costs, particularly since revenue numbers should accelerate, to what degree, that should be possible to evaluate after details being shared from CACLP, where Anteo will commence a full commercial launch for its products.
This could get very dynamic very quickly, IMO.
DEALROOM
New Feature Announcement!
We’re excited to introduce the DealRoom portal, now live on site, providing users with exciting access to private equity opportunities for both pre-IPO and publicly listed companies.
See full details by selecting the new menu item named 'DealRoom' on our main menu bar or click below.
Stay ahead of the market, with HotCopper.